ROCHE HOLDING LTD (RHHBY)
Clinical trial NCT03872180: completion date: 2026-04-30 → 2026-07-15.
Clinical trial NCT03872180: completion date: 2026-04-30 → 2026-07-15.
Clinical trial NCT06904274 updates: 1. completion date: 2027-10-01 → 2027-11-01 2. primary completion date: 2027-10-01 → 2027-11-01
Clinical trial NCT07422285 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-06-30 → 2026-07-24 3. primary completion date: 2026-06-30 → 2026-07-24 4. enrollment: 400 → 405 participants 5. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07283640: start date: 2026-05-18 → 2026-11-18.
Clinical trial NCT06134479: start date: 2023-12-12 → 2023-12-18.
Clinical trial NCT06428396: status: RECRUITING → ACTIVE_NOT_RECRUITING.
Clinical trial NCT07272629: status: ACTIVE_NOT_RECRUITING → COMPLETED.
Clinical trial NCT05955638: primary completion date: 2028-09-01 → 2027-09-01.
Clinical trial NCT07253753 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-06-15 → 2026-06-17 3. primary completion date: 2026-06-15 → 2026-06-17 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT05731128 updates: 1. completion date: 2027-02-19 → 2027-02-22 2. primary completion date: 2026-05-15 → 2026-05-13